Neoleukin Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Donna Cochener-Metcalfe
Chief executive officer
US$993.9k
Total compensation
| CEO salary percentage | 29.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.01% |
| Management average tenure | no data |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Is Neoleukin Therapeutics (NASDAQ:NLTX) In A Good Position To Invest In Growth?
Jul 18
Here's Why We're Watching Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn Situation
Mar 10We're Keeping An Eye On Neoleukin Therapeutics' (NASDAQ:NLTX) Cash Burn Rate
Nov 19Is Neoleukin Therapeutics (NASDAQ:NLTX) In A Good Position To Deliver On Growth Plans?
Jun 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$43m |
| Mar 31 2023 | n/a | n/a | -US$56m |
| Dec 31 2022 | US$994k | US$291k | -US$58m |
Compensation vs Market: Donna's total compensation ($USD993.90K) is above average for companies of similar size in the US market ($USD733.09K).
Compensation vs Earnings: Insufficient data to compare Donna's compensation with company performance.
CEO
Donna Cochener-Metcalfe (48 yo)
less than a year
Tenure
US$993,899
Compensation
Ms. Donna M. Cochener-Metcalfe, J.D., served as General Counsel and Senior Vice President of Legal at Neoleukin Therapeutics, Inc since March 2022 until March 31, 2023 and serves as its Interim Chief Execu...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 9.9yrs | US$206.25k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$143.58k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$320.29k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$132.25k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$142.25k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$140.25k | no data |
4.0yrs
Average Tenure
56yo
Average Age
Experienced Board: NLTX's board of directors are considered experienced (4 years average tenure).